Details for New Drug Application (NDA): 021589
✉ Email this page to a colleague
The generic ingredient in KEMSTRO is baclofen. There are twenty-one drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the baclofen profile page.
Medical Subject Heading (MeSH) Categories for 021589
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Oct 30, 2003 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Oct 30, 2003 | TE: | RLD: | Yes |
Expired US Patents for NDA 021589
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ucb Inc | KEMSTRO | baclofen | TABLET, ORALLY DISINTEGRATING;ORAL | 021589-001 | Oct 30, 2003 | 6,024,981 | ⤷ Subscribe |
Ucb Inc | KEMSTRO | baclofen | TABLET, ORALLY DISINTEGRATING;ORAL | 021589-002 | Oct 30, 2003 | 6,221,392 | ⤷ Subscribe |
Ucb Inc | KEMSTRO | baclofen | TABLET, ORALLY DISINTEGRATING;ORAL | 021589-002 | Oct 30, 2003 | 6,024,981 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription